The “gateway drug” to EV adoption

The “gateway drug” to EV adoption

Hybrid electric vehicles might just be the “gateway drug” of the EV revolution, said an industry analyst. Speaking at the Automotive Aftermarket Retailers of Ontario 2025 Symposium, James Carter of Vision Mobility explained how these technologies are changing both the market and customer habits, noting that getting the mass population to buy into an EV was overambitious. But get them into a hybrid and that may be the stepping stone needed to dri…